Optimizing Parameters for Long-pulsed Nd:YAG Laser for Reducing Hair Shaft Diameter
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT03394235 |
|
Recruitment Status :
Completed
First Posted : January 9, 2018
Last Update Posted : January 30, 2019
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
| Condition or disease | Intervention/treatment | Phase |
|---|---|---|
| Androgenetic Alopecia Hair Loss/Baldness | Device: Long-pulsed, 1064nm Nd-YAG laser | Not Applicable |
Since the beginning of hair transplantation era, hair transplant technique has been greatly improved to achieve the best natural looking of hairline and hair density. Most Asians tend to have large size of hair shaft at the donor area, which often cause unnatural look of the hairline at the frontal area after hair transplantation due to the contrast between the transplanted hair and the original hair.
The idea of reducing the size of the hair shaft in the certain part of donor area before being transplanted to the frontal hairline becomes appealing. This transection is being practiced extensively in the field of cosmetic medicine by using long-pulsed Neodymium-Doped:Yttrium Aluminum Gamet (Nd:YAG), a laser treatment for permanent hair removal and vascular lesions.
| Study Type : | Interventional (Clinical Trial) |
| Actual Enrollment : | 14 participants |
| Allocation: | N/A |
| Intervention Model: | Single Group Assignment |
| Intervention Model Description: | This is a pilot study. We plan to enroll 15 participants who requires to do hair transplantation or normal participants who are eligible for the study. |
| Masking: | None (Open Label) |
| Primary Purpose: | Treatment |
| Official Title: | Optimizing Parameters for Long-pulsed Nd:YAG Laser for Reducing Hair Shaft Diameter at the Donor Area for Hair Transplantation |
| Actual Study Start Date : | February 2, 2018 |
| Actual Primary Completion Date : | November 14, 2018 |
| Actual Study Completion Date : | January 16, 2019 |
| Arm | Intervention/treatment |
|---|---|
|
Experimental: Long-pulsed, 1064nm Nd-YAG laser
All participants will receive long-pulsed, 1064nm Nd-YAG laser treatments with three different parameters at the occipital area.
|
Device: Long-pulsed, 1064nm Nd-YAG laser
This long-pulsed Nd-YAG laser is commonly used for laser hair removal and vascular lesions, but in this study it is used to reduce the size of the hair shaft at the occipital area. |
- Evaluate the changes in hair density at the treated sites. [ Time Frame: 24 weeks ]Evaluate changes in hair density at the treated sites following long-pulsed, 1064 Nd-YAG laser sessions every 8 weeks or until the treatment endpoint is reached before or at 24 weeks.
- Evaluate the changes in hair diameter at the treated sites. [ Time Frame: 24 weeks ]Evaluate the changes in hair diameter at the treated sites following long-pulsed, 1064 Nd-YAG laser sessions every 8 weeks or until the treatment endpoint is reached before or at 24 weeks.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | 25 Years to 60 Years (Adult) |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
- Men and women, aged 25-60 years with AGA or healthy
- Completed informed consent form
Exclusion Criteria:
- Pregnancy or breastfeeding
- Acute infection on the scalp or any systemic infection
- Immunocompromised host
- Chronic wasting diseases
- Use of any medications which may affect hair loss such as anticoagulants, anti-hypertensive, hormones, anticonvulsants, retinoid, mood stabilizers and antidepressants
- Unstable medical problems which may affect hair loss such as thyroid diseases, autoimmune diseases, myocardial infarction, coronary bypass surgery, unstable angina, cardiac arrhythmias, congestive heart failure, cerebrovascular accident and psychiatric problems
- Hair thinning at the occipital area
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03394235
| Thailand | |
| Institute of Dermatology | |
| Bangkok, Thailand | |
| Study Director: | Chinmanat Tangjaturonrusamee, MD | Institute of Dermatology |
| Responsible Party: | Institute of Dermatology, Thailand |
| ClinicalTrials.gov Identifier: | NCT03394235 |
| Other Study ID Numbers: |
007/2561 |
| First Posted: | January 9, 2018 Key Record Dates |
| Last Update Posted: | January 30, 2019 |
| Last Verified: | January 2019 |
| Individual Participant Data (IPD) Sharing Statement: | |
| Plan to Share IPD: | No |
| Plan Description: | Individual participant data is not stated in participants' informed consent. |
| Studies a U.S. FDA-regulated Drug Product: | No |
| Studies a U.S. FDA-regulated Device Product: | No |
| Product Manufactured in and Exported from the U.S.: | No |
|
hair transplant hairline laser hair removal |
|
Alopecia Hypotrichosis Hair Diseases Skin Diseases Pathological Conditions, Anatomical |

